Latest News

Soy didn’t up all-cause mortality in breast cancer survivors

Publish date: January 12, 2019

 

REPORTING FROM NAMS 2018


Pages

Recommended Reading

Extended AI therapy reduces breast cancer recurrence risk, ups fracture risk
MDedge Hematology and Oncology
Data underscore the importance of lifestyle interventions in breast cancer patients
MDedge Hematology and Oncology
QOL is poorer for young women after mastectomy than BCS
MDedge Hematology and Oncology
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
MDedge Hematology and Oncology
Older breast cancer patients given adjuvant chemo live longer
MDedge Hematology and Oncology
Young women opt for mastectomy even when neoadjuvant chemo works well
MDedge Hematology and Oncology
Poor-prognosis cancers linked to highest suicide risk in first year
MDedge Hematology and Oncology
Actionable mutations more likely in women with both breast and uterine cancer
MDedge Hematology and Oncology
Neoadjuvant degarelix more effective than triptorelin for ovarian suppression
MDedge Hematology and Oncology
Daily News Special: SABCS
MDedge Hematology and Oncology